Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer

Vascular-targeted photodynamic therapy (VTP) induces rapid destruction of targeted tissues and is a promising therapy for prostate cancer. However, the resulting immune response, which may play an important role in either potentiating or blunting the effects of VTP, is still incompletely understood....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Oncoimmunology Jg. 8; H. 6; S. e1581528
Hauptverfasser:	Lebdai, Souhil, Gigoux, Mathieu, Alvim, Ricardo, Somma, Alexander, Nagar, Karan, Azzouzi, Abdel Rahmene, Cussenot, Olivier, Merghoub, Taha, Wolchok, Jedd D., Scherz, Avigdor, Kim, Kwanghee, Coleman, Jonathan
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Taylor & Francis 03.06.2019 Taylor & Francis Group
Schlagworte:	CSF-1R immunotherapy MDSCs myeloid cells Original Research Prostate cancer vascular-targeted photodynamic therapy WST11 MDSCs myeloid cells vascular-targeted photodynamic therapy immunotherapy WST11 Prostate cancer CSF-1R
ISSN:	2162-402X, 2162-4011, 2162-402X
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!